Skip to content

3DKNEE Tibial Insert Trial, Size 2, 13mm Right recallZ-1539-2008 · Encore Medical, Lp · initiated Feb 20, 2008

Terminated All recalls posted in August 2008

Is my device affected?

  1. Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
  2. If yours is listed, follow the instructions from Encore Medical, Lp or your healthcare provider. The company's action is summarized under what the company is doing.
  3. Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.

Where to find your model and lot numbers · What recall classes and statuses mean

Why it was recalled

Tibial insert trial incorrectly marked for thickness; device thickness marked correctly as 13mm on the underside of the trial, but is incorrectly marked as 15mm on the side.

FDA root cause category: Error in labeling

What the company is doing

Firm notified consignee by phone and asked them to return any outstanding product on 02/20/08.

Recall details

Recall number
Z-1539-2008
Recall class
Not yet classified by the FDA
Status
Terminated
Initiated by the company
Feb 20, 2008
Posted by the FDA
Aug 20, 2008
Recalling firm
Encore Medical, Lp
Quantity
6 units.
Product code
JWH
FDA submissions
K020114
Distribution
Distribution --- country of Germany.

Product description

3DKNEE Tibial Insert Trial, Size 2, 13mm Right; Part #801-01-640; manufactured by Encore Medical, L.P., Austin, TX 78758. Used in surgery to determine the correct size of 3DKnee component to implant that would allow for the best range of motion and joint stability.

Code information (models, lots, serial numbers)

Lot #53906407

Other devices under the same FDA submission

54 devices cleared under K020114 — the recall does not name any of them by identifier. One submission often covers many models, so they may or may not be affected.

Sources and updates

How recalls are matched to devices · Editorial policy · Report an error on this page